Literature DB >> 22771310

Patterns of polyomavirus SV40 infections and associated cancers in humans: a model.

Janet S Butel1.   

Abstract

A model is described that predicts patterns of polyomavirus SV40 infections and associated cancers in humans. The model proposes that SV40 infections were established in humans primarily by exposure to contaminated oral poliovaccines and that infections persist today in geographic regions where poor sanitation or living conditions allow maintenance of infections transmitted by a fecal/urine-oral route. Predictions from the model include that SV40 infections and virus-associated malignancies will be restricted geographically and demographically and that in developed countries, such as the US, SV40 prevalence rates will be generally very low. The model highlights the importance of selection of populations for investigations of SV40 human infections. This model can explain inconsistencies in the published literature of SV40 infections in humans and can guide the design of future studies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771310      PMCID: PMC3422415          DOI: 10.1016/j.coviro.2012.06.004

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  33 in total

Review 1.  Human exposure to SV40: review and comment.

Authors:  K Shah; N Nathanson
Journal:  Am J Epidemiol       Date:  1976-01       Impact factor: 4.897

Review 2.  Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.

Authors:  A B Sabin
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

3.  Carcinogenicity of malaria and of some polyomaviruses.

Authors:  Véronique Bouvard; Robert A Baan; Yann Grosse; Béatrice Lauby-Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Kurt Straif
Journal:  Lancet Oncol       Date:  2012-03-16       Impact factor: 41.316

4.  Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors.

Authors:  Alfredo Corallini; Elisa Mazzoni; Angelo Taronna; Marco Manfrini; Giovanni Carandina; Giovanni Guerra; Roberto Guaschino; Francesca Vaniglia; Corrado Magnani; Ferruccio Casali; Riccardo Dolcetti; Caterina Palmonari; Giovanni Rezza; Fernanda Martini; Giuseppe Barbanti-Brodano; Mauro G Tognon
Journal:  Hum Immunol       Date:  2012-02-21       Impact factor: 2.850

5.  Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world.

Authors:  A B Sabin
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

6.  Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates.

Authors:  H D Strickler; P S Rosenberg; S S Devesa; J Hertel; J F Fraumeni; J J Goedert
Journal:  JAMA       Date:  1998-01-28       Impact factor: 56.272

Review 7.  Simian virus 40 (SV40) and human cancer: a review of the serological data.

Authors:  Keerti V Shah; Denise A Galloway; Wendy A Knowles; Raphael P Viscidi
Journal:  Rev Med Virol       Date:  2004 Jul-Aug       Impact factor: 6.989

Review 8.  SV40 in adenovirus vaccines and adenovirus-SV40 recombinants.

Authors:  A M Lewis
Journal:  Dev Biol Stand       Date:  1998

Review 9.  Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis.

Authors:  Martyn K White; Kamel Khalili
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

10.  Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma.

Authors:  Eric A Engels; Leonard H Rodman; Morten Frisch; James J Goedert; Robert J Biggar
Journal:  Int J Cancer       Date:  2003-08-20       Impact factor: 7.396

View more
  14 in total

1.  SV40 seroprevalence in two Latin American countries involved in field trials of candidate oral poliovaccines.

Authors:  Connie Wong; Shaojie Zhang; Ervin Adam; Lawrence Paszat; Janet S Butel
Journal:  J Infect       Date:  2019-04-06       Impact factor: 6.072

2.  Assessment of Microbiological Quality of Fresh Vegetables and Oysters Produced in Buenos Aires Province, Argentina.

Authors:  Robertina Viviana Cammarata; Melina Elizabeth Barrios; Sofía Micaela Díaz; Guadalupe García López; María Susana Fortunato; Carolina Torres; María Dolores Blanco Fernández; Viviana Andrea Mbayed
Journal:  Food Environ Virol       Date:  2021-08-27       Impact factor: 2.778

Review 3.  Unboxing the molecular modalities of mutagens in cancer.

Authors:  Smita Kumari; Sudhanshu Sharma; Dia Advani; Akanksha Khosla; Pravir Kumar; Rashmi K Ambasta
Journal:  Environ Sci Pollut Res Int       Date:  2021-10-05       Impact factor: 5.190

4.  Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas.

Authors:  Connie Wong; Regis A Vilchez; Jorge Quiroz; Ervin Adam; Janet S Butel
Journal:  J Infect       Date:  2012-08-30       Impact factor: 6.072

5.  Neutralizing and IgG antibodies against simian virus 40 in healthy pregnant women in Italy.

Authors:  Manola Comar; Connie Wong; Mauro Tognon; Janet S Butel
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

6.  Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents.

Authors:  Angelo Taronna; Elisa Mazzoni; Alfredo Corallini; Ilaria Bononi; Silvia Pietrobon; Giovanni Guerra; Caterina Palmonari; Caterina Borgna-Pignatti; Manola Comar; Massimo Bovenzi; Ferruccio Casali; Roberto Marci; Giovanni Rezza; Giuseppe Barbanti-Brodano; Mauro Tognon; Fernanda Martini
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

7.  Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays.

Authors:  Xiaofang Bian; Garrick Wallstrom; Amy Davis; Jie Wang; Jin Park; Andrea Throop; Jason Steel; Xiaobo Yu; Clive Wasserfall; Desmond Schatz; Mark Atkinson; Ji Qiu; Joshua LaBaer
Journal:  Diabetes       Date:  2015-10-08       Impact factor: 9.461

8.  Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in syrian golden hamsters.

Authors:  Shaojie Zhang; Vojtech Sroller; Preeti Zanwar; Chun Jung Chen; Steven J Halvorson; Nadim J Ajami; Corey W Hecksel; Jody L Swain; Connie Wong; Christopher S Sullivan; Janet S Butel
Journal:  PLoS Pathog       Date:  2014-02-06       Impact factor: 6.823

9.  Fanconi anemia patients are more susceptible to infection with tumor virus SV40.

Authors:  Manola Comar; Daniela De Rocco; Enrico Cappelli; Nunzia Zanotta; Roberta Bottega; Johanna Svahn; Piero Farruggia; Aldo Misuraca; Fabio Corsolini; Carlo Dufour; Anna Savoia
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

10.  Antibodies reacting with Simian Virus 40 capsid protein mimotopes in serum samples from patients affected by uveal melanoma.

Authors:  Ilaria Bononi; Paolo Perri; Alice Begnardi; Alessandra Martini; Elisa Mazzoni; Silvia Bosi; Silvia Pietrobon; Adolfo Sebastiani; Mauro Tognon; Fernanda Martini
Journal:  J Hematol Oncol       Date:  2014-04-29       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.